observations

[키워드] absence Analysis Analytes antibody formation Antibody Response approach bamlanivimab Biomarker biomarker signature Biomarkers Blood change changes in circulation clinical clinical trial Cohort collected connection coronavirus coronavirus 2 coronavirus disease Coronavirus disease 2019 correlated COVID-19 CXCL10 CXCL11 detect disease Elecsys Gene Expression gene expression pattern groups healthy control healthy controls Hospitalized hospitalized COVID-19 patient hospitalized COVID-19 patients IFNγ IgA IgG titer IgG titers IgM IL-6 immune response immunoassay immunological implementation Infection Inflammatory inflammatory protein Inflammatory response interferon response Level Luminex MCP-3 MONITOR monoclonal antibody nasopharyngeal Nasopharyngeal swab nasopharyngeal swab sample Nasopharyngeal swab samples nasopharyngeal swabs Neutralizing not affect not significantly different observation observations Patient patient population patients patients hospitalized patients with COVID-19 peaked Peripheral blood Placebo presence or absence profile Protein Randomized receive reductions reductions in relationship remained repeated measure respiratory RNA sequencing RNA-Seq RNA-seq. SARS-CoV-2 SARS-COV-2 infection Seroconversion serology serum serum biomarker Serum protein serum proteins serum sample serum samples Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 similarities single dose systemic disease therapeutic Treatment Treatment strategies utility viral-induced was performed was used were used while with COVID-19
[DOI] 10.1186/s12967-022-03345-3 PMC 바로가기 [Article Type] Randomized Controlled Trial